Liotta LA - Search Results

1

Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.

Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA. Espina V, et al. Among authors: liotta la. Proteomics Clin Appl. 2009 Aug 1;3(8):874-882. doi: 10.1002/prca.200800001. Proteomics Clin Appl. 2009. PMID: 20871745 Free PMC article.

2

A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.

Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Mol Cell Proteomics. 2008 Oct;7(10):1998-2018. doi: 10.1074/mcp.M700596-MCP200. Epub 2008 Jul 30. Mol Cell Proteomics. 2008. PMID: 18667411 Free PMC article.

3

Protein microarrays: molecular profiling technologies for clinical specimens.

Espina V, Mehta AI, Winters ME, Calvert V, Wulfkuhle J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Proteomics. 2003 Nov;3(11):2091-100. doi: 10.1002/pmic.200300592. Proteomics. 2003. PMID: 14595807 Review.

4

Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.

Liotta LA, Petricoin EF. Liotta LA, et al. J Clin Invest. 2006 Jan;116(1):26-30. doi: 10.1172/JCI27467. J Clin Invest. 2006. PMID: 16395400 Free PMC article.

5

Nanoparticles: potential biomarker harvesters.

Geho DH, Jones CD, Petricoin EF, Liotta LA. Geho DH, et al. Among authors: liotta la. Curr Opin Chem Biol. 2006 Feb;10(1):56-61. doi: 10.1016/j.cbpa.2006.01.003. Epub 2006 Jan 18. Curr Opin Chem Biol. 2006. PMID: 16413816 Review.

6

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.

Wulfkuhle JD, Edmiston KH, Liotta LA, Petricoin EF 3rd. Wulfkuhle JD, et al. Among authors: liotta la. Nat Clin Pract Oncol. 2006 May;3(5):256-68. doi: 10.1038/ncponc0485. Nat Clin Pract Oncol. 2006. PMID: 16683004 Review.

7

Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.

Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston KH, Liotta LA, Petricoin EF 3rd. Speer R, et al. Among authors: liotta la. Cancer Genomics Proteomics. 2007 May-Jun;4(3):157-64. Cancer Genomics Proteomics. 2007. PMID: 17878519 Free article. Review.

8

Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.

VanMeter A, Signore M, Pierobon M, Espina V, Liotta LA, Petricoin EF 3rd. VanMeter A, et al. Among authors: liotta la. Expert Rev Mol Diagn. 2007 Sep;7(5):625-33. doi: 10.1586/14737159.7.5.625. Expert Rev Mol Diagn. 2007. PMID: 17892368 Review.

9

Reverse phase protein microarrays for monitoring biological responses.

Espina V, Wulfkuhle JD, Calvert VS, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Methods Mol Biol. 2007;383:321-36. doi: 10.1007/978-1-59745-335-6_21. Methods Mol Biol. 2007. PMID: 18217695

10

Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.

VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, Petricoin EF 3rd, Liotta LA, Espina V. VanMeter AJ, et al. Among authors: liotta la. Mol Cell Proteomics. 2008 Oct;7(10):1902-24. doi: 10.1074/mcp.M800204-MCP200. Epub 2008 Aug 6. Mol Cell Proteomics. 2008. PMID: 18687633 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters